F-group (family)
376.1.6.2 IBR_1
Ligands and drugs
134
Member domains
37
with ligand contacts (≤ 4 Å)
27.6% of members
27
with DrugDomain annotations
20.1% of members
14
with a DrugBank compound
10.4% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 376.1.6.2 belongs to X-group 376 RING/U-box-like, which binds 3.8 ligand superclasses per 20 proteins, narrower than 92% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
No DrugBank compounds are annotated on this group's domains.
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| ZNmetal | ZINC ION | 37 |
| CL | CHLORIDE ION | 9 |
| D60 | 2-[3-[2,6-bis(fluoranyl)-4-(1~{H}-pyrazol-4-yl)phenyl]-3-oxidanylidene-propyl]-4-(1-methylpyrazol-4-yl)benzoic acid | 6 |
| FHH | methyl 4-[(2-oxidanylidene-1,5,6,7-tetrahydrocyclopenta[b]pyridin-3-yl)carbonylamino]butanoate | 2 |
| NAmetal | SODIUM ION | 2 |
| SY8 | 5-azanylpentan-2-one | 2 |
| D5U | 2-[3-(2-methoxyphenyl)-3-oxidanylidene-propyl]benzoic acid | 1 |
| L68 | 2-[3-[2,6-bis(fluoranyl)-4-(1~{H}-pyrazol-4-yl)phenyl]-3-oxidanylidene-prop-1-enyl]-4-(1-methylpyrazol-4-yl)benzoic acid | 1 |
| L6B | methyl 4-[(2-oxidanylidene-5,6,7,8-tetrahydro-1~{H}-quinolin-3-yl)carbonylamino]but-3-enoate | 1 |
| L6E | [2-(methylamino)-2-oxidanylidene-ethyl] (~{E})-4-[(2-oxidanylidene-5,6,7,8-tetrahydro-1~{H}-quinolin-3-yl)carbonylamino]but-2-enoate | 1 |
| L6H | [2-[3-(cyclooct-4-en-1-yloxycarbonylamino)propylamino]-2-oxidanylidene-ethyl] (~{E})-4-[(2-oxidanylidene-5,6,7,8-tetrahydro-1~{H}-quinolin-3-yl)carbonylamino]but-2-enoate | 1 |